#AANAM – Exploring Mavenclad’s Effects on Immune Cells

#AANAM – Exploring Mavenclad’s Effects on Immune Cells

293206

#AANAM – Exploring Mavenclad’s Effects on Immune Cells

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, held April 17–22. Go here to read stories from the conference. After starting treatment with the multiple sclerosis (MS) therapy Mavenclad (cladribine), some types of immune cells are more affected than others, a new analysis suggests. The findings may have important implications for understanding how Mavenclad works in MS patients, as well as understanding how vaccines still may be effective…

You must be logged in to read/download the full post.